AstraZeneca Covid-19 Vaccine Trial Volunteer Dies In Brazil, Testing To Continue

The regulator said testing of the vaccine would continue after the volunteer's death.

Getty Images

Covid Vaccine Update:  During the clinical trial of the COVID-19 vaccine developed by AstraZeneca and Oxford University, a volunteer from Brazil died, according to the Brazilian Health Authority Anvisa. The authority said that they have received the data and have installed a probe into this matter. Also Read|Coronavirus Update: Apollo Hospitals Ready To Administer Over 7,00,000 Covid-19 Vaccines Per Day The regulator said testing of the vaccine would continue after the volunteer's death. It provided no further details, citing medical confidentiality of those involved in trials. The Federal University of Sao Paulo, which is helping coordinate phase 3 clinical trials in Brazil, separately said that the volunteer was Brazilian but did not say where the person lived. AstraZeneca shares turned negative and were down 1.7%.

 The federal government already has plans to purchase the UK vaccine and produce it at its biomedical research center FioCruz in Rio de Janeiro, while a competing vaccine from China's Sinovac is being tested by Sao Paulo state's research center Butantan Institute.

(With agency inputs)